Enantioselective synthesis of mannostatin A: A new glycoprotein processing inhibitor

DOI: 10.1021/ja00013a071

Source and publish data:

Journal of the American Chemical Society p. 5089 - 5090 (1991)

Update date:2022-08-04

Topics:

Authors:

King King

Ganem Ganem

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/ja00013a071

Full text of DOI:10.1021/ja00013a071

Products guided by the article

Product name:(1R,2R,5S)-1-(methylthio)-2-hydroxy-5-(N-((R)-hydroxyphenylacetyl)amino)cyclopent-3-ene

Cas No:134153-75-6

R&D Labs maybe for 134153-75-6

Hebei Tete Trade Co., Ltd.

Contact:86-311-83160559

Address:shijiazhuang
Changsha Botaniex Inc.

Contact:(86) 731 88718666

Address:Room 1222, Unit 4, Building B, Shangcheng, No.47, Kaiyuan East Road.
CHEM PLUS

Contact:0027-717-456976

Address:2ND FLOOR, 325 VAUSE ROAD, OVERPORT, 4001, SOUTH AFRICA
Hebei Maison Chemical Co.,Ltd

website:http://www.maisonchem.com.cn

Contact:0086-311-83833777

Address:Leitou industrial district, xinji, shijiazhuang city, hebei province,
Jingzhou TianHe Sci&Tech Chemical Co., Ltd.

Contact:86-716-8331612

Address:Jiangjin Road, #18, High-grade technology industries development district, Jingzhou city, Hubei province

Relevant to this article

ALKYL β-IMINO α-H-PERFLUOROESTERS FROM PRIMARY AMINES AND ALKYL α-H-PERFLUOROESTERS

Doi:10.1016/S0040-4039(00)82153-X
(1988)
Synthesis and multidrug resistance reversal activity of dihydroptychantol A and its novel derivatives

Doi:10.1016/j.bmc.2009.05.077
(2009)
New Sterol Derivatives from the Marine Sponge Xestospongia sp.

Doi:10.1002/hlca.201600021
(2016)
S_N2′ alkylation of chiral allylic cyanohydrin O-phosphates with organocuprates

Doi:10.1002/ejoc.200600822
(2007)
Asymmetric Allylic Amination of Morita-Baylis-Hillman Adducts with Simple Aromatic Amines by Nucleophilic Amine Catalysis

Doi:10.1055/s-0037-1611740
(2019)
Synthesis and biological evaluation of [4-(2-phenylethenesulfonylmethyl) phenyl]-quinazolin-4-yl-amines as orally active anti-cancer agents

Doi:10.1016/j.bmcl.2003.10.020
(2004)

Article Doi